Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin’s gastric lymphoma patients

Table 1 Demographics and clinicopathological characteristics of 36 patients with primary gastric lymphoma

Characteristics	Frequency	Percentage (%)
Age of disease presentation (yr)	58.39 ± 15.39 (median: 59, range: 33-82)
Gender
Male	21	58.4
Female	15	41.6
Type of Surgery
Total gastrectomy	10	27
Subtotal gastrectomy	20	55.5
Unknown	6	17.5
Microscopic Margins
Positive margins	5	13.9
Negative Margins	31	86.1
Stage
I	17	47.2
II	7	19.4
III	6	16.7
IV	6	16.7
Histologic Grade
Low grade	15	41.7
Intermediate grade	7	19.4
High grade	14	38.9
Tumor Surface (cm2)	50.04 ± 47.9 (median 29.15, range 1.5-180)
Tumor Thickness (mm)	7.05 ± 4.07 (median: 6, range:1.5- 15)
Tumor Diameter (cm)	6.66 ± 3.8 (median: 5.75, range: 1-15)
Adjuvant Chemotherapy
Yes	25	69.4
No	8	22.3
Unknown	3	8.3